TANG CAPITAL MANAGEMENT LLC Q3 2016 Filing
Filed November 15, 2016
Portfolio Value
$241.1B
Holdings
7
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (7 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 6,197,198 | $106.8B | 44.29% | |
| 2 | —LA JOLLA PHARMACEUTICAL CO | 3,191,165 | $75.9B | 31.49% | |
| 3 | —IGNYTA INC | 3,972,800 | $25.0B | 10.36% | |
| 4 | OPK 3 02/01/33 AIOPKO HEALTH INC | 14,000,000 | $22.0B | 9.14% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 90,215 | $8.3B | 3.46% | |
| 6 | —CYCLACEL PHARMACEUTICALS INC | 359,900 | $2.2B | 0.90% | |
| 7 | —ATYR PHARMA INC | 279,425 | $889.0M | 0.37% |